They regulate elevated blood glucose by triggering pancreatic insulin secretion and signaling the liver to decrease glucose production.[30] Based on their mode of action, DPP-4 inhibitors appear to be of special value in early forms of T2DM, either alone or in combination with other types of oral agents.[31]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.